Pacific Biosciences of California PACB Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's operating cash flow?
- Pacific Biosciences of California (PACB) reported operating cash flow of -$44.69M in Q1 2026.
- How has Pacific Biosciences of California's operating cash flow changed year-over-year?
- Pacific Biosciences of California's operating cash flow decreased by 1.4% year-over-year, from -$44.06M to -$44.69M.
- What is the long-term trend for Pacific Biosciences of California's operating cash flow?
- Over 4 years (2021 to 2025), Pacific Biosciences of California's operating cash flow has grown at a 0.0% compound annual growth rate (CAGR), from -$111.18M to -$111.21M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.